Facts and reflections on COVID-19 and anti-hypertensives drugs

Autores
Marin, Gustavo Horacio
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensivedrug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin IIreceptor blockers (e.g. losartan), many patients from South America, Central America or Spain,have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominousconsequences due to this drop out. For this reason, it is necessary to quickly warn about thissituation and the risks associated with it.
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Materia
COVID-19
Medicines
Side effects
ACE-2
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/108169
Acceder
id CONICETDig_202f6a7dd53f786eb29b48e84693c029
oai_identifier_str oai:ri.conicet.gov.ar:11336/108169
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Facts and reflections on COVID-19 and anti-hypertensives drugsMarin, Gustavo HoracioCOVID-19MedicinesSide effectsACE-2https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensivedrug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin IIreceptor blockers (e.g. losartan), many patients from South America, Central America or Spain,have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominousconsequences due to this drop out. For this reason, it is necessary to quickly warn about thissituation and the risks associated with it.Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaJapan Medical Society2020-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/108169Marin, Gustavo Horacio; Facts and reflections on COVID-19 and anti-hypertensives drugs; Japan Medical Society; Drug Discoveries & Therapeutics; 14; 2; 3-2020; 104-1071881-7831CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.5582/ddt.2020.01017info:eu-repo/semantics/altIdentifier/url/https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01017/_articleinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:33:41Zoai:ri.conicet.gov.ar:11336/108169instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:33:42.227CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Facts and reflections on COVID-19 and anti-hypertensives drugs
title Facts and reflections on COVID-19 and anti-hypertensives drugs
spellingShingle Facts and reflections on COVID-19 and anti-hypertensives drugs
Marin, Gustavo Horacio
COVID-19
Medicines
Side effects
ACE-2
title_short Facts and reflections on COVID-19 and anti-hypertensives drugs
title_full Facts and reflections on COVID-19 and anti-hypertensives drugs
title_fullStr Facts and reflections on COVID-19 and anti-hypertensives drugs
title_full_unstemmed Facts and reflections on COVID-19 and anti-hypertensives drugs
title_sort Facts and reflections on COVID-19 and anti-hypertensives drugs
dc.creator.none.fl_str_mv Marin, Gustavo Horacio
author Marin, Gustavo Horacio
author_facet Marin, Gustavo Horacio
author_role author
dc.subject.none.fl_str_mv COVID-19
Medicines
Side effects
ACE-2
topic COVID-19
Medicines
Side effects
ACE-2
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensivedrug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin IIreceptor blockers (e.g. losartan), many patients from South America, Central America or Spain,have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominousconsequences due to this drop out. For this reason, it is necessary to quickly warn about thissituation and the risks associated with it.
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
description Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensivedrug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin IIreceptor blockers (e.g. losartan), many patients from South America, Central America or Spain,have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominousconsequences due to this drop out. For this reason, it is necessary to quickly warn about thissituation and the risks associated with it.
publishDate 2020
dc.date.none.fl_str_mv 2020-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/108169
Marin, Gustavo Horacio; Facts and reflections on COVID-19 and anti-hypertensives drugs; Japan Medical Society; Drug Discoveries & Therapeutics; 14; 2; 3-2020; 104-107
1881-7831
CONICET Digital
CONICET
url http://hdl.handle.net/11336/108169
identifier_str_mv Marin, Gustavo Horacio; Facts and reflections on COVID-19 and anti-hypertensives drugs; Japan Medical Society; Drug Discoveries & Therapeutics; 14; 2; 3-2020; 104-107
1881-7831
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.5582/ddt.2020.01017
info:eu-repo/semantics/altIdentifier/url/https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01017/_article
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Japan Medical Society
publisher.none.fl_str_mv Japan Medical Society
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613037676298240
score 13.070432

Publicaciones similares